Risks of compounded drugs highlighted amid safety concerns and enforcement actions... Read more

Qualcomm (QCOM) completes Alphawave Semiconductor acquisition to boost data center expansion, reports record $12.3B Q1 revenue ... Read more

First Lady meets with freed hostage Keith Siegel after successful negotiation... Read more

FDA offers instructor-led training on compounding quality and compliance... Read more

FDA approves Darzalex Faspro with VRd for newly diagnosed multiple myeloma ineligible for transplant... Read more

GDUFA Type II API DMF payments fluctuate across fiscal years, with notable peaks in FY 2023 and FY 2025... Read more

Multiple drug guidance documents withdrawn or expired, including COVID-19 protocols and clinical trial standards, impacting regulatory pathways. ... Read more

Nominations sent to the Senate for confirmation, signaling upcoming appointments to key government positions.... Read more

China's MIIT outlines 2026 industrial and technological priorities amid ongoing reforms... Read more

FDA releases on-demand learning library with expert insights on drug development and approval pathways... Read more

FDA approves REDEMPLO for familial chylomicronemia syndrome with 59% triglyceride reduction; trial included diverse, global adult participants.... Read more

FDA's CDER Small Business & Industry Assistance launches new online training and resources for drug development stakeholders... Read more

FDA’s SBIA enhances small pharma compliance with new resources, training, and industry updates to streamline drug development processes. ... Read more

FDA approves LEROCHOL, a PCSK9 inhibitor for hypercholesterolemia, based on three trials showing ~50-60% LDL-C reduction across diverse populations. ... Read more

Health fraud scams target consumers with unproven medical products online... Read more

FDA expands multilingual training access with Spanish captions for key drug development resources... Read more

FDA Launches New Resources for Small Pharma Businesses... Read more

FDA approves REDEMPLO for familial chylomicronemia syndrome with 59% triglyceride reduction; trial included diverse global participants.... Read more

President emphasizes commitment to gender equity in sports on National Women and Girls in Sports Day... Read more

FDA issues new guidance on medical device cybersecurity and clinical trial endpoints... Read more

Recall of Abbott FreeStyle Libre 3 and Plus sensors due to incorrect glucose readings... Read more

Allied Digital Services Ltd posts second-highest Q3 revenue ever at ₹247.4 Cr, but auditor flags ₹117 Cr interest-free loans and asset verification gaps.... Read more

Allied Digital Services Ltd posts record Q3 revenue at ₹247.4 Cr, highest ever for the quarter, but net profit falls 21% YoY amid rising costs and tax hit.... Read more

Allied Digital Services hits record Q3 revenue at ₹247 Cr, highest ever for Q3, but net profit falls 21% YoY on tax and expense rise.... Read more

Allied Digital Services Ltd posts record Q3 revenue at ₹247.4 Cr, 45% above Q3 average, but net margin slumps to 5.6%, lowest in 6 quarters.... Read more

Allied Digital Services Ltd reports Q3 FY26 revenue of ₹247 crore, net profit down 16% YoY... Read more

Phillips 66 (PSX) reports Q4 earnings of $2.9B, including $239M accelerated depreciation after ceasing fuel production at Los Angeles Refinery ... Read more

FDA urges compounders to verify API and excipient quality to prevent patient harm; issues alerts on contaminated ingredients and enforces supply chain oversight.... Read more

FDA warns against unapproved GLP-1 weight loss drugs amid safety, quality, and counterfeit concerns... Read more

AbbVie (ABBV) reports full-year 2025 revenue of $61.16B, up 8.6%, driven by immunology and neuroscience growth despite Humira exclusivity loss ... Read more